Medtronic CIP326
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Pediatric Subjects

Type of Study:
Type 1 diabetes patients who are 7 to 13 years

Study Length:
3.5 months

Target Age/Sex:
7-13 years, Male and Female

Benefits:
Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

The main purpose of this cohort is to test the Digital Twin insulin delivery algorithm and the Meal Prediction algorithm.

Enroll Now

Enroll Now

Address
Address
City
State/Province
Zip/Postal
If you don't have a primary care physician, just type "Do not have a primary care physician"